ABIVAX Société Anonyme (EPA:ABVX)
5.80
+0.05 (0.87%)
Apr 1, 2025, 12:44 PM CET
ABIVAX Société Anonyme Revenue
In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M EUR with 135.94% growth. ABIVAX Société Anonyme had revenue of 4.01M in the half year ending December 31, 2024, with 78.20% growth.
Revenue
10.79M
Revenue Growth
+135.94%
P/S Ratio
33.59
Revenue / Employee
156.41K
Employees
69
Market Cap
364.45M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.79M | 6.22M | 135.94% |
Dec 31, 2023 | 4.57M | 69.00K | 1.53% |
Dec 31, 2022 | 4.51M | 302.00K | 7.19% |
Dec 31, 2021 | 4.20M | 4.19M | 29,921.43% |
Dec 31, 2020 | 14.00K | 21.00K | -300.00% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sanofi | 44.29B |
EssilorLuxottica Société anonyme | 26.51B |
Sartorius Stedim Biotech | 2.78B |
bioMérieux | 3.98B |
Eurofins Scientific SE | 6.95B |
Ipsen | 3.57B |
Virbac | 1.40B |
emeis Société anonyme | 5.43B |
ABIVAX Société Anonyme News
- 4 days ago - ABIVAX: Undercovered, Late-Stage French Company With Upcoming Catalysts - Seeking Alpha
- 5 days ago - Abivax publishes financial reports with the French and U.S. securities regulatory agencies - GlobeNewsWire
- 7 days ago - Abivax reports FY results - Seeking Alpha
- 8 days ago - Abivax Announces Full Year 2024 Financial Results - GlobeNewsWire
- 5 weeks ago - Abivax to Host Key Opinion Leader (KOL) Webcast on March 17, 2025 - GlobeNewsWire
- 2 months ago - Abivax Publishes 2025 Financial Calendar - GlobeNewsWire
- 2 months ago - Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress - GlobeNewsWire
- 2 months ago - Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment - GlobeNewsWire